The Great Deceiver: miR-2392’s Hidden Role in Driving SARS-CoV-2 Infection
Summary
MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a circulating miRNA, miR-2392, that is directly involved with SARS-CoV-2 machinery during host infection. Specifically, we found that miR-2392 was key in driving downstream suppression of mitochondrial gene expression, increasing inflammation, glycolysis, and hypoxia as well as promoting many symptoms associated with COVID-19 infection. We demonstrate miR-2392 is present in the blood and urine of COVID-19 patients tested, but not detected in COVID-19 negative patients. These findings indicate the potential for developing a novel, minimally invasive, COVID-19 detection method. Lastly, using both in vitro human and in vivo hamster models, we have developed a novel miRNA-based antiviral therapeutic targeting miR-2392 that significantly reduces SARS-CoV-2 viability and may potentially inhibit a COVID-19 disease state in the host.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (11760)
- Bioengineering (8760)
- Bioinformatics (29211)
- Biophysics (14986)
- Cancer Biology (12104)
- Cell Biology (17417)
- Clinical Trials (138)
- Developmental Biology (9429)
- Ecology (14189)
- Epidemiology (2067)
- Evolutionary Biology (18316)
- Genetics (12246)
- Genomics (16807)
- Immunology (11875)
- Microbiology (28106)
- Molecular Biology (11607)
- Neuroscience (61019)
- Paleontology (452)
- Pathology (1872)
- Pharmacology and Toxicology (3238)
- Physiology (4964)
- Plant Biology (10429)
- Synthetic Biology (2888)
- Systems Biology (7341)
- Zoology (1651)